Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphology.

Sullivan LM, Smolkin ME, Frierson HF Jr, Galgano MT.

Am J Surg Pathol. 2008 Nov;32(11):1608-12. doi: 10.1097/PAS.0b013e31816d71c4.

PMID:
18753946
2.

Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.

McCluggage WG, Shah R, Connolly LE, McBride HA.

Int J Gynecol Pathol. 2008 Jan;27(1):92-100.

PMID:
18156982
3.

Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.

Paner GP, McKenney JK, Barkan GA, Yao JL, Frankel WL, Sebo TJ, Shen SS, Jimenez RE.

Am J Surg Pathol. 2011 Jun;35(6):787-98. doi: 10.1097/PAS.0b013e3182189c11.

PMID:
21572312
4.

The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.

Kaimaktchiev V, Terracciano L, Tornillo L, Spichtin H, Stoios D, Bundi M, Korcheva V, Mirlacher M, Loda M, Sauter G, Corless CL.

Mod Pathol. 2004 Nov;17(11):1392-9.

5.

Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation.

Park KJ, Bramlage MP, Ellenson LH, Pirog EC.

Appl Immunohistochem Mol Morphol. 2009 Jan;17(1):8-11. doi: 10.1097/PAI.0b013e318174f012.

PMID:
18776815
6.

[Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].

Gaggero G, Sola S, Mora M, Fulcheri E.

Pathologica. 2003 Aug;95(4):185-91. Italian.

PMID:
14577202
7.

Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.

Park KJ, Kiyokawa T, Soslow RA, Lamb CA, Oliva E, Zivanovic O, Juretzka MM, Pirog EC.

Am J Surg Pathol. 2011 May;35(5):633-46. doi: 10.1097/PAS.0b013e31821534b9.

PMID:
21490443
8.

SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.

Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.

Am J Surg Pathol. 2016 Mar;40(3):419-32. doi: 10.1097/PAS.0000000000000553.

PMID:
26551622
10.

CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinoma.

Saad RS, Ismiil N, Dubé V, Nofech-Mozes S, Khalifa MA.

Am J Clin Pathol. 2009 Oct;132(4):531-8. doi: 10.1309/AJCP7E5ASGOENPFP.

PMID:
19762530
11.

CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites.

De Lott LB, Morrison C, Suster S, Cohn DE, Frankel WL.

Arch Pathol Lab Med. 2005 Sep;129(9):1100-5.

PMID:
16119980
12.
13.
14.

Expression of the intestinal marker Cdx2 in secondary adenocarcinomas of the colorectum.

Groisman GM, Bernheim J, Halpern M, Brazowsky E, Meir A.

Arch Pathol Lab Med. 2005 Jul;129(7):920-3.

PMID:
15974817
15.

p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.

Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Judson K, Ronnett BM.

Am J Surg Pathol. 2007 May;31(5):653-63.

PMID:
17460447
16.

A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.

Carleton C, Hoang L, Sah S, Kiyokawa T, Karamurzin YS, Talia KL, Park KJ, McCluggage WG.

Am J Surg Pathol. 2016 May;40(5):636-44. doi: 10.1097/PAS.0000000000000578.

PMID:
26685087
17.

Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer.

Leite KR, Mitteldorf CA, Srougi M, Dall'oglio MF, Antunes AA, Pontes J Jr, Camara-Lopes LH.

Ann Diagn Pathol. 2008 Aug;12(4):260-6. doi: 10.1016/j.anndiagpath.2007.11.001. Epub 2008 Apr 18.

PMID:
18620992
19.

CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall.

Mazziotta RM, Borczuk AC, Powell CA, Mansukhani M.

Appl Immunohistochem Mol Morphol. 2005 Mar;13(1):55-60.

PMID:
15722794
20.

Expression of CDX-2 and Ki-67 in different grades of colorectal adenocarcinomas.

Sen A, Mitra S, Das RN, Dasgupta S, Saha K, Chatterjee U, Mukherjee K, Datta C, Chattopadhyay BK.

Indian J Pathol Microbiol. 2015 Apr-Jun;58(2):158-62. doi: 10.4103/0377-4929.155304.

Supplemental Content

Support Center